Loading clinical trials...
Loading clinical trials...
Italian multicenter observational study to evaluate time to clinical hepatic decompensation, quality of life, effectiveness, and safety of tremelimumab plus durvalumab in patients with advanced or unr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
AstraZeneca Clinical Study Information Center AstraZeneca Clinical Study Information Center
CONTACT
+1877240information.center@astrazeneca.comLead Sponsor
AstraZeneca
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT06902246 · Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma
NCT07478302 · Advanced Unresectable Hepatocellular Carcinoma
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
Research site
Ancona
Research site
Bergamo
Research site
Foggia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions